A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 297
- Registration Number
- NCT03544944
- Locations
- 🇰🇷
Taejoon Pharmaceutical Co., Ltd., Seoul, Korea, Republic of
A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 146
- Registration Number
- NCT03419975
- Locations
- 🇰🇷
Chan Yun, Kim, Seoul, Korea, Republic of
Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Target Recruit Count
- 158
- Registration Number
- NCT02461719
- Locations
- 🇰🇷
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath